The report also reviews the competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

1. X-ray Systems Market to 2019 :Global Industry Analysis Trends
Enhanced Imaging Capability, Better Procedural Efficiency and
Portability to Drive Future Growth of Digital X-ray Systems
X-ray Systems Market to 2019 – Enhanced Imaging Capability, Better Procedural Efficiency and
Portability to Drive Future Growth of Digital X-ray Systems looks at the market, competitive landscape,
and trends for the three X-ray systems market segments: digital X-ray systems, analog X-ray systems
and retrofit X-ray systems. The report provides comprehensive information on the key trends affecting
these segments, and key analytical content on the market dynamics. The report also reviews the
competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as
details of important M&A deals. It is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
View Full Report With TOC: http://www.researchmoz.us/x-ray-systems-market-to-2019-enhanced-
imaging-capability-better-procedural-efficiency-and-portability-to-drive-future-growth-of-digital-x-
ray-systems-report.html
Scope
Key geographies: the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia
and Brazil
Information on market size for the three X-ray systems market segments: digital X-ray systems, analog X-
ray systems and retrofit X-ray systems.
Annualized market revenue data, forecast to 2019, and company share data for 2011
Qualitative analysis of key trends in the X-ray systems market
Information on the leading market players, the competitive landscape, and the leading technologies in the
market
Reasons to Buy
Develop business strategies by understanding the trends and developments driving the global X-ray
systems market
Design and enhance your product development, marketing, and sales strategies
Exploit M&A opportunities by identifying the market players with the most innovative pipelines
Develop market-entry and market expansion strategies
Identify the key players best positioned to take advantage of the emerging market opportunities

2. Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a
robust return
Identify, understand and capitalize on the next big thing in the X-ray systems market landscape
Make more informed business decisions from the insightful and in-depth analysis of the global X-ray
systems market and the factors shaping it
Buy a copy of this report:
http://www.researchmoz.us/sample/checkout.php?rep_id=165773&type=S
Related Reports:
1. Adult and Adolescent Vaccines Market to 2018
Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adult
and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis
of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent
vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of
the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. The
report analyzes the market for adult and adolescent vaccines in the US, and the top five countries in
Europe (the UK, Germany, France, Italy and Spain) and Japan.
The report discusses the global pipeline for adult and adolescent vaccines across various stages of
development. The report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by GBI Research’s team of industry experts. GBI
Research found that the adult and adolescent vaccines market in the top seven markets was valued at
$7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007–
2011 historic period. The market is projected to witness a growth of 5.6% during the 2011–2018 forecast
period to reach $10.5 billion. The growth in the adult and adolescent vaccines market is driven by
increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved for use in people
aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19% during the
forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011.
2. Seasonal Influenza Vaccine Market in Asia-Pacific to 2018
Traditional egg based manufacturing of seasonal influenza vaccines is being replaced with
cell culture vaccines. Cell culture based production of vaccines is expected to reduce the
problems associated with the production and use of seasonal influenza vaccines which will
further increase the vaccination coverage in the APAC region. GBI Research Analysis shows
that the seasonal influenza vaccine market in the APAC Region is a fast growing market.
This is due to increased vaccination coverage against seasonal influenza in the region. GBI

3. Research forecasts the market to grow at double digit Compounded Annual Growth Rate
(CAGR) of 9% during the period 2011–2018 from $1,015m in 2011 to $1,879m by 2018.
This growth is driven by factors such as increasing awareness on influenza caused by threat
of pandemic influenza, increasing vaccination coverage because of the governments’
support, growing population in the APAC region and entry of novel vaccines and production
technologies. GBI Research finds that the Philippines’ seasonal influenza vaccine market is
the most attractive in the seasonal influenza vaccine market for Asia-Pacific region both in
terms of value and growth rate. Other attractive markets in terms of growth rate are
Malaysia’s and Singapore’s seasonal influenza vaccine markets. Australia’s seasonal
influenza vaccine market is also a large sized attractive market forecast to grow at a
healthy growth rate during the period 2011–2018.
3. Oncology Therapeutics Market in India to 2018
Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based
Pricing to Fuel Price Wars and Intense Competition Among Domestic and
Multinational Players’, which provides in-depth analysis of the key therapeutic
indications of oncology, breast cancer, colorectal cancer, prostate cancer, lung
cancer and Non-Hodgkin’s Lymphoma (NHL), with forecasts until 2018. It also
looks at treatment usage patterns and includes insights into the oncology R&D
pipeline. The Indian oncology therapeutics market for breast cancer, lung cancer,
colorectal cancer, prostate cancer and NHL was estimated to be worth $153.3m in
2011, having grown at a Compound Annual Growth Rate (CAGR) of 12.7% from
2004. It is expected to reach $238.8m in 2018 at a CAGR of 6.5% from 2011.
The slower growth in the forecast period is mainly due to the reduction in the
price of leading marketed products for breast cancer, colorectal cancer, lung
cancer and NHL after all 348 drugs on the National List of Essential Medicines
(NLEM) are brought under price control regulations. The limitations of the current
market are unclear patent laws, restrictive pricing and reimbursement policies,
ailing infrastructure, and insufficient government aid. Low patient affordability is
also a major restraint, and one that reimbursement and insurance policies must
address if the market is to develop in the future.
For More Information Kindly Contact:
Mrs.Sheela AK
Tel:+1-518-618-1030

4. Email: sales@researchmoz.us